MMT

Kaleido Biosciences, Inc.

Application Filed: 2018-12-19
Trademark Application Details
Trademark Logo MMT

Mark For: MMT® trademark registration is intended to cover the categories of therapeutic pharmaceuticals for medical use for the treatment of dysbiosis, infectious diseases, inflammatory diseases, cancer, gastro-intestinal diseases, metabolic diseases and disorders, cardiovascular diseases and disorders, immune disorders, kidney diseases and disorders, liver diseases and disorders, organ failure, autoimmune diseases, brain conditions, genetic disorders, drug-induced toxicities, allergies, depression, autism spectrum disorders, obesity, and diabetes in humans; dietetic foods adapted for medical use; dietary supplements; nutritional supplements; nutraceuticals for the treatment of dysbiosis, infectious diseases, inflammatory diseases, cancer, gastro-intestinal diseases, metabolic diseases and disorders, cardiovascular diseases and disorders, immune disorders, kidney diseases and disorders, liver diseases and disorders, organ failure, autoimmune diseases, brain conditions, genetic disorders, drug-induced toxicities, allergies, depression, autism spectrum disorders, obesity, and diabetes in humans; medical diagnostic reagents and assays for testing body fluids for microorganisms for modifying the microbial composition or metabolic output of the human microbiome. [all]

Status

2021-01-18 UTC
LIVE APPLICATION Under Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and that this application has been assigned to an examiner.


Research OneLook Acronym Finder
Serial Number88235670
Registration Number1482563
Mark Literal ElementsMMT
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTRADEMARK
RegisterPRINCIPAL
Current LocationINTENT TO USE SECTION 2019-10-22
Basis1(b)
Class StatusACTIVE
Primary US Classes
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseNo
Current UseNo
Intent To UseYes
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameChristina M. Licursi, Esq.
Attorney Docket NumberV027920003US
Law Office AssignedL40
Employee NameSPILS, CAROL A

Timeline

2018-12-19Application Filed
2019-08-27Published
2019-08-27Published for Opposition
2019-10-22Location: INTENT TO USE SECTION
2019-10-22Status: Live/Pending
2019-10-22Transaction Date
2020-10-16Status: A second request for extension of time to file a Statement of Use has been granted.

Trademark Parties (Applicants & Owners)

Party: Kaleido Biosciences, Inc.
Address65 Hayden Avenue Lexington, MASSACHUSETTS UNITED STATES 02421
Legal Entity TypeCorporation
Legal Entity StateDELAWARE

Documents

DrawingJPEG2018-12-19
TEAS RF New ApplicationMULTI2018-12-19
Notation to FileXML2019-03-19
XSearch Search SummaryAPPLICATION/XML2019-03-19
Notation to FileXML2019-03-21
Offc Action OutgoingMULTI2019-03-22
Response to Office ActionXML2019-06-19
Amendment and Mail Process CompleteMULTI2019-06-28
TRAM Snapshot of App at Pub for OppostnMULTI2019-07-23
Notice of PublicationXML2019-08-07
Notification Of Notice of PublicationXML2019-08-07
OG Publication ConfirmationAPPLICATION/XML2019-08-27
Notice of AllowanceXML2019-10-22
Extension of Time to File SOUMULTI2020-04-21
ITU Extension ApprovalXML2020-04-23
ITU Unit ActionMULTI2020-04-23
Extension of Time to File SOUXML2020-10-16
ITU Extension ApprovalXML2020-10-20
ITU Unit ActionAPPLICATION/XML,IMAGE/JPEG2020-10-20

Attorney of Record

CHRISTINA M. LICURSI, ESQ.
WOLF GREENFIELD & SACKS, P.C.
600 ATLANTIC AVENUE
BOSTON, MA 02210

Good, Services, and Codes


IC 005. US 006 018 044 046 051 052. G & S: therapeutic pharmaceuticals for medical use for the treatment of dysbiosis, infectious diseases, inflammatory diseases, cancer, gastro-intestinal diseases, metabolic diseases and disorders, cardiovascular diseases and disorders, immune disorders, kidney diseases and disorders, liver diseases and disorders, organ failure, autoimmune diseases, brain conditions, genetic disorders, drug-induced toxicities, allergies, depression, autism spectrum disorders, obesity, and diabetes in humans; dietetic foods adapted for medical use; dietary supplements; nutritional supplements; nutraceuticals for the treatment of dysbiosis, infectious diseases, inflammatory diseases, cancer, gastro-intestinal diseases, metabolic diseases and disorders, cardiovascular diseases and disorders, immune disorders, kidney diseases and disorders, liver diseases and disorders, organ failure, autoimmune diseases, brain conditions, genetic disorders, drug-induced toxicities, allergies, depression, autism spectrum disorders, obesity, and diabetes in humans; medical diagnostic reagents and assays for testing body fluids for microorganisms for modifying the microbial composition or metabolic output of the human microbiome

International Codes:5
U.S. Codes:006,018,044,046,051,052
Type CodeType
GS0051therapeutic pharmaceuticals for medical use for the treatment of dysbiosis, infectious diseases, inflammatory diseases, cancer, gastro-intestinal diseases, metabolic diseases and disorders, cardiovascular diseases and disorders, immune disorders, kidney diseases and disorders, liver diseases and disorders, organ failure, autoimmune diseases, brain conditions, genetic disorders, drug-induced toxicities, allergies, depression, autism spectrum disorders, obesity, and diabetes in humans; dietetic foods adapted for medical use; dietary supplements; nutritional supplements; nutraceuticals for the treatment of dysbiosis, infectious diseases, inflammatory diseases, cancer, gastro-intestinal diseases, metabolic diseases and disorders, cardiovascular diseases and disorders, immune disorders, kidney diseases and disorders, liver diseases and disorders, organ failure, autoimmune diseases, brain conditions, genetic disorders, drug-induced toxicities, allergies, depression, autism spectrum disorders, obesity, and diabetes in humans; medical diagnostic reagents and assays for testing body fluids for microorganisms for modifying the microbial composition or metabolic output of the human microbiome

Trademark Filing History

DescriptionDateProceeding Number
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2020-10-20
TEAS EXTENSION RECEIVED2020-10-16
EXTENSION 2 GRANTED2020-10-1698765
EXTENSION 2 FILED2020-10-1698765
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2020-04-23
TEAS EXTENSION RECEIVED2020-04-21
EXTENSION 1 GRANTED2020-04-2198765
EXTENSION 1 FILED2020-04-2198765
NOA E-MAILED - SOU REQUIRED FROM APPLICANT2019-10-22
PUBLISHED FOR OPPOSITION2019-08-27
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2019-08-27
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2019-08-07
APPROVED FOR PUB - PRINCIPAL REGISTER2019-07-20
TEAS/EMAIL CORRESPONDENCE ENTERED2019-06-2773296
CORRESPONDENCE RECEIVED IN LAW OFFICE2019-06-2773296
ASSIGNED TO LIE2019-06-2573296
TEAS RESPONSE TO OFFICE ACTION RECEIVED2019-06-19
NOTIFICATION OF NON-FINAL ACTION E-MAILED2019-03-226325
NON-FINAL ACTION WRITTEN2019-03-2274307
NON-FINAL ACTION E-MAILED2019-03-226325
ASSIGNED TO EXAMINER2019-03-1474307
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2019-01-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed